REG - MyHealthChecked PLC - Director/PDMR Shareholding
MyHealthChecked Plc
("MyHealthChecked" or the "Company")
Directors/PDMR Dealing
MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, announces that following Admission of the Placing Shares, the Firm Subscription Shares and Conversion Shares to trading this morning, the Participating Directors have acquired interests in new ordinary shares of 0.1p ("Ordinary Shares") as set out below, at a subscription price of 1.75p per Ordinary Share.
Name
Number of Subscription Shares
Number of Ordinary Shares held post admission of the Placing Shares, the Firm Subscription Shares and the Conversion Shares
% of Ordinary Share Capital held post admission of the Placing Shares, the Firm Subscription Shares and the Conversion Shares
Penny McCormick
400,000
1,650,000
0.24%
Maddy Kennedy
400,000
1,650,000
0.24%
Lyn Rees
428,571
1,991,071
0.29%
Adam Reynolds
1,428,571
9,513,293
1.37%
All terms used above are as defined in the RNS of 29 January 2021.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Penny McCormick
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
MYHEALTHCHECKED plc
b)
LEI
213800RBHY6LZDG13168
CO4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares
Identification code
ISIN: GB00BYZ2R301
b)
Nature of the transaction
Subscription for cash
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.0175
400,000
d)
Aggregated information
- Aggregated volume
As above
- Price
e)
Date of the transaction
19 February 2021
f)
Place of the transaction
London Stock Exchange, AIM
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Maddy Kennedy
2
Reason for the notification
a)
Position/status
Chief Financial Officer
b)
Initial notification/Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
MYHEALTHCHECKED plc
b)
LEI
213800RBHY6LZDG13168
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares
Identification code
ISIN: GB00BYZ2R301
b)
Nature of the transaction
Subscription for cash
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.0175
400,000
d)
Aggregated information
- Aggregated volume
As above
- Price
e)
Date of the transaction
19 February 2021
f)
Place of the transaction
London Stock Exchange, AIM
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Lyn Rees
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
MYHEALTHCHECKED plc
b)
LEI
213800RBHY6LZDG13168
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares
Identification code
ISIN: GB00BYZ2R301
b)
Nature of the transaction
Subscription for cash
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.0175
428,571
d)
Aggregated information
- Aggregated volume
As above
- Price
e)
Date of the transaction
19 February 2021
f)
Place of the transaction
London Stock Exchange, AIM
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Adam Reynolds
2
Reason for the notification
a)
Position/status
Non-Executive Chairman
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
MYHEALTHCHECKED plc
b)
LEI
213800RBHY6LZDG13168
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares
Identification code
ISIN: GB00BYZ2R301
b)
Nature of the transaction
Subscription for cash
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.0175
1,428,571
d)
Aggregated information
- Aggregated volume
As above
- Price
e)
Date of the transaction
19 February 2021
f)
Place of the transaction
London Stock Exchange, AIM
For further information please visit http://www.myhealthcheckedplc.com/ or contact:
MyHealthChecked plc
Penny McCormick, Chief Executive Officer
via Walbrook PR
Maddy Kennedy, Chief Financial Officer
SPARK Advisory Partners Limited (NOMAD)
Tel: +44 (0)20 3368 3550
Neil Baldwin
Oberon Investments (Broker)
Tel: +44 (0)203 179 5344
Mike Seabrook
Walbrook PR Ltd (Media & Investor Relations)
Tel: +44 (0)20 7933 8780 or myhealthchecked@walbrookpr.com
Paul McManus
Mob: +44(0)7980 541 893
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company with two diverse, customer-facing at-home testing brands in its portfolio:
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the recent acquisition of The Genome Store. The tests will be made available on line, and would be viable for over the counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Mylo targets the personalized mobile health market, with a primary focus on hormone testing and increasing a woman's chances of naturally getting pregnant, and providing insight to unexplained infertility. The myLotus range of IVDs are CE-marked and are expected to be beneficial to users who have been unable to conceive after 6 months of trying. This highly motivated target group of women won't typically be offered medical intervention until after 12 months of unsuccessfully trying to conceive, with IVF not usually offered until after two years of trying to conceive. Research indicates couples start to take positive action ahead of this time typically with little medical support to help them do so.
The myLotus range of IVDs are currently the UK's only consumer product which allows both quantitative and qualitative home (self-test) test measurement of a woman's personal luteinizing hormone (LH) during ovulation and human chorionic gonadotropin ("hCG") hormone level during pregnancy.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHKKLBFFLLEBBB
Recent news on Myhealthchecked
See all newsREG - MyHealthChecked PLC - Trading Update
AnnouncementREG - MyHealthChecked PLC - Holding(s) in Company
AnnouncementREG - MyHealthChecked PLC - Grant of Options
AnnouncementREG - MyHealthChecked PLC - Half-Year Report
AnnouncementREG - MyHealthChecked PLC - Notice of Results
Announcement